Rankings
▼
Calendar
NAUT
Nautilus Biotechnology, Inc.
$289M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$154,000
Net Income
$718,765
EPS (Diluted)
$0.10
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$122,436
Free Cash Flow
-$122,436
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$147M
Total Liabilities
$142M
Stockholders' Equity
$5M
Cash & Equivalents
$1M
← FY 2019
All Quarters
Q2 2019 →
NAUT Q1 2019 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
